Pubblicazioni

Elenco pubblicazioni

  1. D’Abundo,L., Bassi,C., Callegari,E., Moshiri,F., Guerriero, P., Michilli, A., Mora, F., Casadei Gardini, A., Sangiovanni, A., Piscaglia,F., Sabbioni, S., Gramantieri, L., Negrini, M. Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy. Scientific Reports (2024) 14(1): 18551. DOI: https://doi.org/10.1038/s41598-024-69548-4
  2. Favale, N., Farina, R., Carrieri, A.,Simonelli, A., Severi, M., Sabbion, S.,Trombelli, L., Scapoli, C. Functional profile of oral plaque microbiome: further insight into the bidirectional relationship between type 2 diabetes and periodontitis. Mol Oral Microbiol (2023). 39(2): 62-79.  doi: 10.1111/omi.12418. Epub ahead of print. PMID: 37257865
  3. Lupini, L., Bassi, C., Guerriero, P. et al. Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing. World J Microbiol Biotechnol 39, 37 (2022) 23(15): 8546. https://doi.org/10.1007/s11274-022-03469-0
  4. Bassi, C.; Guerriero, P.; Pierantoni, M.; Callegari, E.; Sabbioni, S. Novel Virus Identification through Metagenomics: A Systematic Review. Life 2022, 12(12), 2048. https://doi.org/10.3390/life12122048
  5. Maranini, B, Ciancio G., Ferracin, M., and Cultrera, R., Negrini, M., Sabbioni, S., Govoni, M. MicroRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review. Life (Basel), 2022 Feb 15;12(2):288. doi: 10.3390/life12020288.
  6. Favale, N., Costa, S., Scapoli, C., Carrieri, A., Sabbioni, S., Tamburini, E., Benazzo, A., Bernacchia, G. Reconstruction of Acinetobacter johnsonii ICE_NC genome using hybrid de novo genome assemblies and identification of the 12α-hydroxysteroid dehydrogenase gene. Journal of Applied Microbiology, 2022; 133(3): 1506–1519. https://doi.org/10.1111/jam.15657
  7. Callegari, E., Guerriero, P., Bassi, C., D’Abundo, L., Frassoldati, A.,Simoni, E., Astolfi,L., Silini,E. M., Sabbioni, S.and Massimo Negrini miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models. Mol Ther Nucleic Acids 2022, 29:538-549. doi: 10.1016/j.omtn.2022.07.015
  8. Lupini, L:, , Roberta Roncarati, R., Belluomini, L., Lancia, F., Bassi, C., D’Abundo, L., Michilli, A., Guerriero, P., Fasano, A., Tiberi, E., Salamone, A., Cosi, D.M.,Saccenti E., Tagliatti, V., Maestri,I., Sabbioni, S., Volinia, S., Gafà, R., Lanza, G., Frassoldati, A. and Negrini, M. Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with “Oncogene-Addicted”Advanced Lung Adenocarcinoma: A Real-World Clinical Study. International Journal o f Molecular Sciences 2022; 23(15):8546. doi: 10.3390/ijms23158546
  9. Scavizzi F, Bassi C, Lupini L, Guerriero P, Raspa M, Sabbioni S. A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing. Anim Microbiome. 2021; 3:53. https://doi.org/10.1186/s42523-021-00113-4
  10. Laprovitera N, Salamon I, Gelsomino F, Porcellini E, Riefolo M, Garonzi M, Tononi P, Valente S, Sabbioni S, Fontana F, Manaresi N, D'Errico A, Pantaleo MA, Ardizzoni A, Ferracin M. Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches. Front Cell Dev Biol. 2021 Jun 10:9:666156. doi: 10.3389/fcell.2021.666156.
  11. Laprovitera N, Salamon I, Gelsomino F, Porcellini E, Riefolo M, Garonzi M, Tononi P, Valente S, Sabbioni S, Fontana F, Manaresi N, D'Errico A, Pantaleo MA, Ardizzoni A, Ferracin M. Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches. Front Cell Dev Biol. 2021 Jun 10:9:666156. doi: 10.3389/fcell.2021.666156.
  12. Roncarati R., Lupini, L., Miotto E., Saccenti, E., Mascetti, S., Morandi, L., Bassi, C., Rasio, D., Callegari, E., Conti, V., Rinaldi, R., Lanza, G., Gafà, R., Papi, A., Frassoldati, A., Sabbioni, S., Ravenna, F., Casoni, G.L., Negrini, M. Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer Mol Oncol. 2020; Sep;14(9):2163-2175. DOI: 10.1002/1878-0261.12713
  13. Shankaraiah, R. C., Callegari, E., Guerriero, P., Rimessi, A., Pinton, P., Gramantieri, L., Silini, E. M., Sabbioni, S., Negrini, M. Metformin prevents liver tumorigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma Oncogene 2019, 38: 7035-7045 doi: 10.1038/s41388-019-0942-z; hdl:11392/2409804.
  14. Shankaraiah, R. C., Gramantieri, L., Fornari F., Sabbioni, S., Callegari, E., Negrini, M. Animal Models of Hepatocellular Carcinoma Prevention Cancers (Basel) 2019 Nov 14;11(11):1792 doi: 10.3390/cancers11111792.
  15. Farina, R., Severi, M., Carrieri, A., Miotto, E., Sabbioni, S., Trombelli, L., Scapoli, C. Whole metagenomic shotgun sequencing of the subgingival microbiome of diabetics and non-diabetics with different periodontal conditions. Arch Oral Biol 2019;104:13-23.  doi: 10.1016/j.archoralbio.2019.05.025.
  16. Callegari E., Domenicali M., Shankaraiah RC., D'Abundo L., Guerriero P., Giannone F., Baldassarre M., Bassi C., Elamin B.K., Zagatti B., Ferracin M., Fornari F., Altavilla G., Blandamura S., Silini E.M., Gramantieri L., Sabbioni S., Negrini M.  MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer, Mol Ther Nucleic Acids 14 (2019) 239-250 https://doi.org/10.1016/j.omtn.2018.11.018.
  17. Guerriero, P., Moshiri, F., Lupini, L., Sabbioni, S., Negrini, M., Callegari, E. Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy, Hepatoma Res (2019)5:6 doi: 10.20517/2394-5079.2018.108.
  18. Callegari E., D'Abundo L., Guerriero P., Simioni C., Elamin B.K., Russo M., Cani A., Bassi C., Zagatti B, Giacomelli L., Blandamura S., Moshiri F., Ultimo S., Frassoldati A., Altavilla G., Gramantieri L., Neri L.M., Sabbioni S., Negrini M., miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model, Mol Ther Nucleic Acids 11(2018) 485-493 doi: 10.1016/j.omtn.2018.04.002
  19. Shankaraiah R.C., Veronese A., Sabbioni S., Negrini M., Non-coding RNAs in the reprogramming of glucose metabolism in cancer Cancer Lett 419 (2018), 167-174 doi: 10.1016/j.canlet.2018.01.048
  20. Moshiri F., Salvi A., Gramantieri L., Sangiovanni A., Guerriero P., De Petro G., Bassi C., Lupini L., Sattari A., Cheung D., Veneziano D., Nigita G., Shankaraiah R.C., Portolani N., Carcoforo P., Fornari F., Bolondi L., Frassoldati A., Sabbioni S., Colombo M., Croce C.M., Negrini M., Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma Oncotarget, 9 (2018), 15350-15364 doi: 10.18632/oncotarget.24601.
  21. Casoni, G. L., Miotto, E., Saccenti, E., Mascetti, S., Rasio, D., Marchi, I., Rinaldi, r., Lanza, G., Papi, A., Sabbioni, S., Ravenna, F., Negrini, M. Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR European respiratory journal (2017) 50: PA734. doi:10.1183/1393003.congress-2017.PA734
  22. D'Abundo L., Callegari E., Bresin A., Chillemi A., Elamin B. K., Guerriero P., Huang X., Saccenti E., Emaa Hussein, Casciano F., Secchiero P., Zauli G., Calin G. A., Russo G., Lee L. J., Croce C. M., Marcucci G., Sabbioni S., Malavasi F., and Negrini M., Anti-Leukemic Activity of Microrna-26a in a Chronic Lymphocytic Leukemia Mouse Model, Oncogene (2017) 36 (47): 6617-6626 doi: 10.1038/onc.2017.269.
  23. Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M: Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget 2016 Apr 22;7(21):31361–31371 doi: 10.18632/oncotarget.8913.
  24. Ferracin M, Salamon I, Lupini L, Miotto E, Sabbioni S, Negrini M: Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR. J Vis Exp 2016:e54102. doi: 10.3791/54102.
  25. Mangolini A, Ferracin M, Zanzi MV, Saccenti E, Ebnaof SO, Vultaggio Poma V, Sanz JM, Passaro A, Pedriali M, Frassoldati A, Querzoli P, Sabbioni S, Carcoforo P, Hollingsworth A, Negrini M: Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. Biomarker Res 2015, 3:12. doi: 10.1186/s40364-015-0037-0
  26. Lupini L, Bassi C, Mlcochova J, Musa G, Russo M, Vychytilova-Faltejskova P, Svoboda M, Sabbioni S, Nemecek R, Slaby O, Negrini M: Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients. BMC Cancer 2015, 15:808. DOI 10.1186/s12885-015-1752-5.
  27. Ferrajoli A, Ivan C, Ciccone M, Shimizu M, Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, Rabe KG, Rassenti LZ, Van Roosbroeck K, Manning JT, Yuan Y, Zhang X, Shanafelt TD, Wierda WG, Sabbioni S, Tarrand JJ, Estrov Z, Radovich M, Liang H, Negrini M, Kipps TJ, Kay NE, Keating M, Calin GA: Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine 2015, 2(6):572-582. doi: 10.1016/j.ebiom.2015.04.018.
  28. Callegari E, Gramantieri L, Domenicali M, D'Abundo L, Sabbioni S, Negrini M: MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ 2015, 22(1):46-57. https://doi.org/10.1038/cdd.2014.136
  29. Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, Narducci MG, Caprini E, Pekarsky Y, Croce CM, Sabbioni S, Russo G, Negrini M: miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Emicro-TCL1 mouse model. Oncotarget 2015, 6:23. doi: 10.18632/oncotarget.4415.
  30. Callegari E, Domenicali M, Gramantieri L, Negrini M, Sabbioni S: Emerging role of microRNAs in the treatment of hepatocellular carcinoma. Gastrointest Cancer Targets Ther 2015, 5:89-102. doi: 10.5005/jp-journals-10018-1095.
  31. Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D’Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri A: MicroRNAome expression in chronic lymphocytic leukemia: comparison with normal B cell subsets and correlations with prognostic and clinical parameters. Clin Cancer Res 2014, 20(15):4141-4153. doi: 10.1158/1078-0432.CCR-13-2497.
  32. Moshiri F, Callegari E, D'Abundo L, Corra F, Lupini L, Sabbioni S, Negrini M: Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma. Gastroenterol Hepatol Bed Bench 2014, 7(1):43-54.
  33. Fornari F, Milazzo M, Galassi M, Callegari E, Veronese A, Miyaaki H, Sabbioni S, Mantovani V, Marasco E, Chieco P, Negrini M, Bolondi L, Gramantieri L: p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma. Mol Cancer Res 2014, 12(2):203-216. doi: 10.1158/1541-7786.MCR-13-0312-T.
  34. Lupini L, Bassi C, Ferracin M, Bartonicek N, D'Abundo L, Zagatti B, Callegari E, Musa G, Moshiri F, Gramantieri L, Corrales FJ, Enright AJ, Sabbioni S, Negrini M: miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Frontiers in Genetics 2013, 4:64. https://doi.org/10.3389/fgene.2013.00064
  35. Callegari E, Elamin KB, D’Abundo L, Falzoni S, Donvito G, Moshiri F, Milazzo M, Altavilla G, Giacomelli L, Fornari F, Hemminki A, Di Virgilio F, Gramantieri L, Negrini M, Sabbioni S: Anti-tumor activity of a miR-199-dependent oncolytic adenovirus. PLoS ONE 2013, 8(9):e73964.  doi: 10.1371/journal.pone.0073964.
  36. Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M: Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther 2013, 6:1167-1178. doi: 10.2147/OTT.S36161
  37. Negrini M, Miotto E, Sabbioni S, Cardin R, Rugge M, Tieppo C, Piciocchi M, Maddalo G, Nitti D, Farinati F: MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer. Eur J Cancer Prev 2012, 21(5):442-448. doi: 10.1097/CEJ.0b013e32834f7536.
  38. Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L, Gramantieri L: In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 2012, 227(3):275-285. doi: 10.1002/path.3995.
  39. Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, Fornari F, Giacomelli L, D'Abundo L, Ferracin M, Bassi C, Zagatti B, Corra F, Miotto E, Lupini L, Bolondi L, Gramantieri L, Croce CM, Sabbioni S, Negrini M: Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 2012, 56(3):1025-1033. doi: 10.1002/hep.25747.
  40. Negrini M, Gramantieri L, Sabbioni S, Croce CM: microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem 2011, 11(6):500-521. https://doi.org/10.2174/187152011796011037
  41. Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M: MicroRNA response to environmental mutagens in liver. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2011, 717(1-2):67-76. doi:10.1016/j.mrfmmm.2011.03.015.
  42. Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, Dianzani MU, Negrini M, Barrera G: MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic Biol Med 2009, 46(2):282-288. doi: 10.1016/j.freeradbiomed.2008.10.035.
  43. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M: MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 2009, 15(16):5073-5081. doi: 10.1158/1078-0432.CCR-09-0092.
  44. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L: MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009, 69(14):5761-5767. doi: 10.1158/0008-5472.CAN-08-4797.
  45. Negrini M, Veronese A, Ferracin M, Zagatti B, Sabbioni S, Corallini A, Calin GA, Croce CM: Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways. Minerva Biotecnol 2008, 20:13-21.
  46. Clementi R, Bargigli L, Sabbioni S, Levi-Montalcini R. Open letter to Senator Rita Levi- Montalcini. Science 2008, 319(5870):1615.
  47. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M: MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008, 12(6A):2189-2204.
  48. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M: MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008, 27(43):5651-5661.
  49. Ferracin M, Gafa R, Miotto E, Veronese A, Pultrone C, Sabbioni S, Lanza G, Negrini M: The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile. J Pathol 2008, 214(5):594-602.
  50. Ulazzi L, Sabbioni S, Miotto E, Veronese A, Angusti A, Gafa R, Manfredini S, Farinati F, Sasaki T, Lanza G, Negrini M: Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. Mol Cancer 2007, 6:17.
  51. Sabbioni S, Callegari E, Spizzo R, Veronese A, Altavilla G, Corallini A, Negrini M: Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag. Cancer Gene Ther 2007, 14(3):297-305.
  52. Sabbioni S, Callegari E, Manservigi M, Argnani R, Corallini A, Negrini M, Manservigi R: Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA. Gene Ther 2007, 14(5):459-464.
  53. Negrini M, Ferracin M, Sabbioni S, Croce CM: MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007, 120(Pt 11):1833-1840.
  54. Martini F, Corallini A, Balatti V, Sabbioni S, Pancaldi C, Tognon M. Simian virus 40 in humans. Infect Agent Cancer. 2007, 2:13.
  55. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007, 67(13):6092-6099.
  56. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M: BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 2006, 577:319-341.
  57. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65(16):7065-7070.
  58. Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafa R, Lanza G, Negrini M: Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res 2004, 64(22):8156-8159.
  59. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M: Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 2004, 318(1):1-9.
  60. Sabbioni S, Miotto E, Veronese A, Sattin E, Gramantieri L, Bolondi L, Calin GA, Gafa R, Lanza G, Carli G, Ferrazzi E, Feo C, Liboni A, Gullini S, Negrini M: Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn 2003, 7(3-4):201-207.
  61. Altavilla, G., Caputo, A., Trabanelli, C., Brocca Cofano, E., Sabbioni, S., Menegatti, M. A., Barbanti-Brodano, G., Corallini, A. Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane. Eur J Cancer, 40: 275-283, 2004.
  62. Mecucci C, La Starza R, Negrini M, Sabbioni S, Crescenzi B, Leoni P, Di Raimondo F, Krampera M, Cimino G, Tafuri A, Cuneo A, Vitale A, Foa R: t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia. Br J Haematol 2000, 109(4):788-793.
  63. Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Milani R, Bardi A, Minotto C, Agostini P, De Angeli C, Narducci MG, Sabbioni S, Russo G, Negrini M, Castoldi G: Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features. J Clin Oncol 2000, 18(13):2607-2614.
  64. Sabbioni S, Veronese A, Trubia M, Taramelli R, Barbanti-Brodano G, Croce CM, Negrini M: Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD. Cytogenet Cell Genet 1999, 86(3-4):214-218.
  65. Schwienbacher C, Sabbioni S, Campi M, Veronese A, Bernardi G, Menegatti A, Hatada I, Mukai T, Ohashi H, Barbanti-Brodano G, Croce CM, Negrini M: Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples. Proc Natl Acad Sci U S A 1998, 95(7):3873-3878.
  66. Scelfo R, Sabbioni S, Barbanti-Brodano G, Negrini M: Subchromosomal assignment1 of the TSSC1 gene to human chromosome band 11p15.5 near the HBB gene cluster. Cytogenet Cell Genet 1998, 83(1-2):52-53.
  67. Schwienbacher C, Sabbioni S, Barbanti-Brodano G, Negrini M: Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15. Eur J Hum Genet 1997, 5(4):214-217.
  68. Sabbioni S, Barbanti-Brodano G, Croce CM, Negrini M: GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Res 1997, 57(20):4493-4497.
  69. Sabbioni S, Negrini M, Rimessi P, Manservigi R, Barbanti-Brodano G: A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells. Arch Virol 1995, 140(2):335-339.
  70. Negrini M, Sabbioni S, Ohta M, Veronese ML, Rattan S, Junien C, Croce CM: Seven megabase yeast artificial chromosome contig at region 11p15: identification of a yeast artificial chromosome spanning the breakpoint of a chromosomal translocation found in a case of Beckwith-Wiedemann syndrome. Cancer Res 1995, 55(13):2904-2909.
  71. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, Croce CM.: Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 1995, 55(14):3003-3007.
  72. Negrini M, Cuneo A, Nakamura T, Baffa R, Sabbioni S, Alder H, Castoldi G, Croce CM: A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia. Cancer Genet Cytogenet 1995, 83(1):65-70.
  73. Sabbioni S, Negrini M, Possati L, Bonfatti A, Corallini A, Sensi A, Stanbridge EJ, Barbanti-Brodano G: Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells. Int J Cancer 1994, 57(2):185-191.
  74. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brodano G, Croce CM: Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 1994, 54(5):1331-1336.
  75. Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, Barbanti-Brodano G, Croce CM: Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res 1994, 54(7):1818-1824.
  76. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994, 54(8):2095-2097.
  77. Negrini M, Castagnoli A, Sabbioni S, Recanatini E, Giovannini G, Possati L, Stanbridge EJ, Nenci I, Barbanti-Brodano G: Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11. Oncogene 1992, 7(10):2013-2018.
  78. Negrini M, Castagnoli A, Pavan JV, Sabbioni S, Araujo D, Corallini A, Gualandi F, Rimessi P, Bonfatti A, Giunta C, et al.: Suppression of tumorigenicity and anchorage-independent growth of BK virus-transformed mouse cells by human chromosome 11. Cancer Res 1992, 52(5):1297-1303.
  79. Negrini M, Sabbioni S, Arthur RR, Castagnoli A, Barbanti-Brodano G: Prevalence of the archetypal regulatory region and sequence polymorphisms in nonpassaged BK virus variants. J Virol 1991, 65(9):5092-5095.
  80. Negrini M, Rimessi P, Sabbioni S, Caputo A, Balboni PG, Gualandri R, Manservigi R, Grossi MP, Barbanti-Brodano G: High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B. Biotechniques 1991, 10(3):344-353.
  81. Negrini M, Rimessi P, Mantovani C, Sabbioni S, Corallini A, Gerosa MA, Barbanti-Brodano G: Characterization of BK virus variants rescued from human tumours and tumour cell lines. J Gen Virol 1990, 71 ( Pt 11):2731-2736.

 

Capitoli su libri a diffusione internazionale

Barbanti-Brodano G; Sabbioni S; Martini F; Negrini M; Corallini A; Tognon M BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: Polyomaviruses And Human Diseases

Curatele di libri a diffusione internazionale

Authors, Practical Handbook on the 3Rs in the Context of the Directive 2010/63/EU, Editors: Gianni Dal Negro, Silvia Sabbioni, Elsevier, 2021, Paperback ISBN: 9780128211809, eBook ISBN: 9780128212523.